14 September 2022
Metastatic rhabdomyosarcoma: results of the European paediatric Soft tissue sarcoma Study Group MTS 2008 study and pooled analysis with the concurrent BERNIE study
J Clin Oncol. 2022 Jun 16;JCO2102981. doi: 10.1200/JCO.21.02981. Online ahead of print.
Outcome for children with metastatic rhabdomyosarcoma remains poor with survival rates between…Read more
27 September 2021
Role of 18F-FDG-PET/CT in the staging of metastatic rhabdomyosarcoma: A report from the European paediatric Soft tissue sarcoma Study Group
The largest comparison study between PET/CT and the standard radiology workup in Rhabdomyosarcoma
The aim of this study was to evaluate the ability of 18F-FDG-PET/CT in the staging of metastatic…Read more
31 August 2021
Randomized Phase II Trial of Vincristine-Irinotecan With or Without Temozolomide, in Children and Adults With Relapsed or Refractory Rhabdomyosarcoma: A European Paediatric Soft tissue Sarcoma Study Group and Innovative Therapies for Children With Cancer Trial.
The VIT-0910 trial was the first study of the European Paediatric Soft Tissue Sarcoma Study Group…Read more
01 July 2021
Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG)
The EpSSG NRSTS 2005 protocol represents the first European-based prospective protocol specifically…Read more
26 April 2021
April 29 and 30 are two days dedicated to EpSSG meetings.
On Thursday we invite you to join the Assembly as a member. Please check your email as the SIOPe Secretariat have sent you the invitation link to join.
Moreover, for a full participation to the EpSSG meetings and not only, please register at the SIOPe annual meeting. (See below how to register)
We are looking forward to having you with us!
REGISTRATION GUIDELINES All participants must Create an Account and register via the Online…Read more